Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease
Public ClinicalTrials.gov record NCT00125138. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of three target doses of melperone compared to placebo in the treatment of psychosis associated with Parkinson's disease. Subjects will be enrolled at approximately 20 investigational sites in the United States (U.S.) and 15 Ex-US sites. The maximum study duration will be 10 weeks. Subjects will have the option of continuing in an open-label extension study.
Study identification
- NCT ID
- NCT00125138
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2005
- Primary completion
- Feb 29, 2008
- Completion
- Mar 31, 2008
- Last update posted
- Jun 16, 2011
2005 – 2008
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Neurospecialists, PLLC | Tucson | Arizona | 85741 | — |
| Bradenton Research Center, Inc | Bradenton | Florida | 34205 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| The University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Quest Research Institute | Bingham Farms | Michigan | 48025 | — |
| Struthers Parkinson's Center, Park Nicollet Health Services | Golden Valley | Minnesota | 55427 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Neurology Consultants of the Carolinas | Charlotte | North Carolina | 28204 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45267 | — |
| Neurology Associates | San Antonio | Texas | 78217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00125138, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2011 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00125138 live on ClinicalTrials.gov.